RINIZIDE FORTE DT TABLET

RINIZIDE FORTE DT TABLET is used to treat tuberculosis in children. Tuberculosis is an infectious disease that mainly affects the lungs but can also spread to other body parts such as the kidneys, brain, spine, and bone marrow.
 
RINIZIDE FORTE DT TABLET contains Rifampicin, and Isoniazid. Rifampicin inhibits DNA-dependent RNA polymerase activity in the bacteria. Isoniazid inhibits the biosynthesis of mycolic acid, which is the major component of the cell wall. Together, RINIZIDE FORTE DT TABLET kills Mycobacterium tuberculosis which causes TB (tuberculosis).
 
In some cases, RINIZIDE FORTE DT TABLET may cause side effects such as nausea, vomiting, diarrhoea, stomach pain, and loss of appetite. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to the doctor if the side effects persist or worsen.
 
Let your doctor know if your child is allergic to any of the components in RINIZIDE FORTE DT TABLET. Keep your doctor informed about your child's health condition and medications to rule out any side effects/interactions.

RINIZIDE FORTE DT TABLET is used in the treatment of Tuberculosis. The detailed uses of RINIZIDE FORTE DT TABLET are as follows:

• Treatment of Active Tuberculosis (TB): RINIZIDE FORTE DT TABLET is used in combination therapy to treat active TB infections in children. Rifampicin and Isoniazid work synergistically to kill Mycobacterium tuberculosis by disrupting bacterial protein synthesis and cell wall formation, helping reduce symptoms like persistent cough, fever, and weight loss.
• Latent Tuberculosis Infection (LTBI): RINIZIDE FORTE DT TABLET is used in children who have been exposed to TB but do not yet show symptoms. It helps prevent the progression from latent to active TB, especially in high-risk groups such as those with weakened immune systems.
• Tuberculous Meningitis and Disseminated TB: RINIZIDE FORTE DT TABLET may be part of a broader regimen to treat severe forms of TB, such as TB meningitis or miliary TB, due to its ability to penetrate the central nervous system and systemic circulation effectively.
• Preventive Therapy in High-Risk paediatric Contacts: RINIZIDE FORTE DT TABLET is used as a prophylactic treatment for children who have been in close contact with TB-positive individuals, aiming to stop the infection before it becomes active.

• RINIZIDE FORTE DT TABLET should be administered one hour before or two hours after meals, or as directed by the doctor.
• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safety.
• Administer the prescribed dose to the child using the measuring cup/dosing syringe.
• Shake well before use.

RINIZIDE FORTE DT TABLET belongs to the group of medicines called anti-tuberculosis drugs primarily used to treat and prevent tuberculosis. RINIZIDE FORTE DT TABLET contains two anti-mycobacterial agents, Rifampicin and Isoniazid. Rifampicin inhibits DNA-dependent RNA polymerase activity in the bacteria. Isoniazid inhibits the biosynthesis of mycolic acid, which is the major component of the cell wall. Together, RINIZIDE FORTE DT TABLET kills Mycobacterium tuberculosis which causes TB (tuberculosis).

Do not give RINIZIDE FORTE DT TABLET to the child if he/she is allergic to any of the components in RINIZIDE FORTE DT TABLET, if he/she has acute liver disease, drug-induced liver disease, if the child has experienced liver damage linked to rifampicin or isoniazid, or if the child is taking anti-fungal (voriconazole) or medicines for HIV infection (protease inhibitors). RINIZIDE FORTE DT TABLET may cause liver damage; consult your doctor if the child experiences symptoms such as unexplained loss of appetite, nausea, vomiting, jaundice, dark urine, persistent fatigue for more than 3 days, abdominal pain and tenderness. Consult a doctor if your child gets flu-like symptoms such as headache, fever, or muscle ache. Inform the doctor if your child has HIV infection, epilepsy, psychiatric disorder, diabetes, porphyria, phenylketonuria (metabolic disorder), peripheral neuropathy (tingling sensation in hands and feet), kidney or liver problems, if your child is allergic to ethionamide or niacin (nicotinic acid), or if your child is taking cortisone or any cortisone-like drug.